Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Countering Immunotherapy Resistance With Novel Combinations in Advanced Biliary Tract Cancers

NCT07437287 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT07437287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07437287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Countering Immunotherapy Resistance With Novel Combinations in Advanced Biliary Tract Cancers
Lead sponsor
UNICANCER
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
October 31, 2031
Enrollment
160 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer (btc)